Risk Factors for Nonresponse to Therapy in Kawasaki Disease

Journal of Pediatrics

Volumn 153, Issue 3, 2008, Pages 365-368

  Ashouri, Negar ^a   Takahashi, Masato ^b   Dorey, Frederick ^b   Mason, Wilbert ^b  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INFLIXIMAB; METHYLPREDNISOLONE; STEROID;

ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MEDICAL RECORD REVIEW; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RETREATMENT; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT FAILURE; TREATMENT RESPONSE;

BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 49349093008     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.03.014     Document Type: Article

References (19)

1. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (Jpn J Allergy) 16 (1967) 178-222
2. Melish M.E., Hicks R.M., and Larson E.J. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 130 (1976) 599-607
3. Taubert K.A., Rowley A.H., and Shulman S.T. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119 (1991) 279-282
4. Newburger J.W., Takahashi M., Beiser A.S., Burns J.C., Bastian J., Chung K.J., et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324 (1991) 1633-1639
5. Newburger J.W., Takahashi M., Burns J.C., Beiser A.S., Chung K.J., Duffy C.E., et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315 (1986) 341-347
6. Burns J.C., Capparelli E.V., Brown J.A., Newburger J.W., and Glode M.P. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17 (1998) 1144-1148
7. Durongpisitkul K., Soongswang J., Laohaprasitiporn D., Nana A., Prachuabmoh C., and Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki Disease. Pediatric Cardiology 24 (2003) 145-148
8. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110 (2004) 2747-2771
9. Dajani A.S., Taubert K.A., Gerber M.A., Shulman S.T., Ferrieri P., Freed M., et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 87 (1993) 1776-1780
10. Koren G., Lavi S., Rose V., and Rowe R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108 (1986) 388-392
11. Sano T., Kurotobi S., Matsuzaki K., Yamamoto T., Maki I., Miki K., et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166 (2007) 131-137
12. Wallace C.A., French J.W., Kahn S.J., and Sherry D.D. Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrics 105 (2000) e78
13. Terai M., Honda T., Yasukawa K., Higashi K., Hamada H., and Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 108 (2003) 325-330
14. Tsai M.H., Huang Y.C., Yen M.H., Li C.C., Chiu C.H., Lin P.Y., et al. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin. J Pediatr 148 (2006) 38-43
15. Rosenfeld E.A., Shulman S.T., Corydon K.E., Mason W.H., Takahashi M., and Kuroda C. Comparative safety and efficacy of two immune globulin products in Kawasaki disease. J Pediatr 126 (1995) 1000-1003
16. Durongpisitkul K., Gururaj V.J., Park J.M., and Martin C.F. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96 (1995) 1057-1061
17. Terai M., and Shulman S.T. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131 (1997) 888-893
18. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33 (1991) 805-810
19. Beiser A.S., Takahashi M., Baker A.L., Sundel R.P., and Newburger J.W. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 81 (1998) 1116-1120